BioGenex offers wide-ranging antibodies for several IHC Panel for initial differentiation, tumor origin, treatment methods, and prognosis. All BioGenex antibodies are validated on human tissues to ensure sensitivity and specificity. Comprehensive IHC Panels include a range of mouse monoclonal, rabbit monoclonal, and polyclonal antibodies to choose from.   

BioGenex offers a vast spectrum of high-quality antibodies for both diagnostic and research laboratories. BioGenex strives to support efforts in clinical diagnostics and drug discovery development as we continue to expand our antibody product line offering in both ready-to-use and concentrated formats for both manual and automation systems. 


B&T Cell Associated Lymphoma Panel

There are two types of lymphocytes, B cells, or B-lymphocytes: which make antibodies to fight bacteria and other infections. T cells, or T-lymphocytes: which kill bacteria, viruses, fungi, and abnormal cells and trigger the B cells to make antibodies.

View Brochure

Bladder Cancer Panel

Bladder disease starts when urothelial cells mutates and develop a mass called a tumor. Urothelial cells additionally line the renal pelvis and ureters. Malignant growth that develops in the renal pelvis and ureters is additionally viewed as a type of bladder cancer and is frequently called upper tract bladder cancer.

View Brochure

Breast Cancer Panel

Cancer begins when healthy cells in the breast change and grow out of control, forming a mass or sheet of cells called a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

View Brochure

Cervical Cancer Panel

Cervical cancer is most often diagnosed between the ages of 35 and 44. About 15% of cervical cancers are diagnosed in women over age 65. It is rare for women younger than 20 to develop cervical cancer.

View Brochure

Colorectal and Stomach Cancer Panel

The colon and rectum make up the large intestine, which plays an important role in the body’s ability to process waste.

View Brochure

Esophagus Cancer Panel

There are 2 major types of esophageal cancer a) Squamous cell carcinoma, which is a type of esophageal cancer starts in squamous cells that line the esophagus, b) Adenocarcinoma develops in the glandular tissue in the lower part of the esophagus where the esophagus and the stomach come together.

View Brochure

Germ Cell Tumor Panel

Germ cell tumors are the cancer of reproductive cells. Germ cell tumors occur as cancer of the testicles (testicular cancer) or cancer of the ovaries (ovarian cancer). Some germ cell tumors occur in other areas of the body, such as the abdomen, brain and chest.

View Brochure

Head and Neck Cancer Panel

Head and neck cancer is a collective term for different cancers that includes a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and mouth.

View Brochure

Kidney Cancer Panel

Kidney cancer begins when healthy cells in 1 or both kidneys change and grow out of control, forming a mass called a renal cortical tumor. A tumor can be malignant, indolent, or benign. A malignant tumor is cancerous, meaning it can grow and spread to other parts of the body.

View Brochure

Liver Cancer Panel

Liver cancer is generally classified as primary or secondary. Primary liver cancer begins in the cells of the liver. Secondary liver cancer develops when cancer cells from another organ spread to the liver.

View Brochure

Lung Cancer Panel

Lung cancer is the second most common cancer and the leading cause of cancer death for men and women.

View Brochure

Melanoma Panel

Melanocytes produce the skin’s pigment or color. Melanoma begins when healthy melanocytes change and grow out of control, forming a cancerous tumor

View Brochure

Muscle Cancer Panel

There are many types of soft tissue tumors, and not all of them are cancerous. Many benign tumors are found in soft tissues.

View Brochure

Neuroendocrine Tumor Panel

Neuroendocrine tumors are cancer of the specialized cells of the neuroendocrine system. They can have the cellular properties of both hormone-producing endocrine cells and nerve cells.

View Brochure

Ovarian Cancer Panel

Ovarian cancer accounts for 2.5% of cancers in women and 5% of deaths from cancer. The 5-year survival rate for women with all types of ovarian, fallopian tube, and peritoneal cancers is 47%.

View Brochure

Pancreatic Cancer Panel

Pancreatic cancer one of the difficult to diagnose cancer since there is no specific screening test. The early-stage pancreatic cancer shows no signs or symptoms, making it difficult to diagnose.

View Brochure

Pituitary Gland Cancer Panel 

The pituitary gland also called as master endocrine gland is part of endocrine system that regulates hormoes that regulate several body functions.

View Brochure

Prostate and Testicular Cancer Panel

Prostate cancer is the most common cancer among men and the average diagnosis age is 66. Testicular Cancer: The general 5-year survival rate for men with testicular cancer is 95%.

View Brochure

Vascular Tumor Panel

Vascular tumours are a common cause of soft issue masses, particularly in young adults, and may be confused clinically with other soft tissue tumours, especially if there is no overlying skin discoloration.

View Brochure